...Shira Buchrits; Danielle Fredman; Kim Ben Tikva Kagan; Anat Gafter-Gvili Background: The new severe acute respiratory syndrome coronavirus 2 has emerged as a global pandemic that threatens thousands around the world. Observational cohort studies have demonstrated that cancer patients have inferior...

...Phaedon Dimitrios Zavras; Vikas Mehta; Sanjay Goel; Kith Pradhan; Henny H. Billett Background: Increased rates of thromboembolism (TE) have been reported in patients with COVID-19, even without prior predisposition to thrombosis. Cancer patients are already predisposed to a hypercoagulable state...

...George M. Rodgers; Jeffrey A. Gilreath Cancer-related anemia (CRA) is a commonly occurring problem for patients with cancer regardless of whether they are receiving treatment with chemotherapy or immunotherapy. It may result from one or more processes (decreased production, increased destruction...

..., instructions or products referred to in the content or advertisements. Fetal hemoglobin α ߝFetoprotein Cancer Immunoassay Hepatoma Embryonal cell Acta haemal. 58: 288-293 (1977) Fetal Hemoglobin and «-Fetoprotein in Various Malignancies' David S. C hudwin, Donald L. R ucknagel, A aron P. Scholnik...

...Yoram Cohen; Jamal Zidan; Dan McShan 205 patients with solid cancer, underwent bone marrow biopsy using a Jamshidi needle, regular type. 32 (16%) biopsies were positive for bone marrow metastases. Results were correlated with those of skeletal radioisotope scans, X-ray films and the complaint...

...Mark N. Levine; Agnes Y.Y. Lee Venous thromboembolism is a common complication in patients with cancer. The management of deep vein thrombosis and pulmonary embolism can be a considerable challenge in patients with cancer. The cancer itself and associated treatments contribute to an ongoing...

...Andrea Piccioli; Paolo Prandoni Since Trousseau’s time numerous studies have addressed the relationship between cancer and venous thromboembolism (VTE) providing firm evidence of the increased risk of subsequent clinically overt malignancy during the follow-up of patients with idiopathic VTE...

...Hau C. Kwaan; Leo I. Gordon Thrombotic microangiopathy, manifesting as thrombotic thrombocytopenic purpura (TTP) or hemolytic uremic syndrome, is a common complication in cancer patients. It shares the pathogenic microvascular occlusive lesion and many clinical manifestations as the classical TTP...

...Manuel Monreal; Ester Davant Today many patients with cancer have indwelling long-term central venous catheters. Benefits from catheter use include increased ease of administration of either chemotherapy or other drugs. However, these patients are prone to a number of complications, including deep...

...Andrew J. Gale; Stuart G. Gordon Tumor cells produce tissue factor, cancer procoagulant, plasminogen activators and other factors that interact with the coagulation system, the fibrinolytic system and vascular or blood cells such that they can upset the normal homeostasis and balance between...

...I. Gouin-Thibault; A. Achkar; M.M. Samama Thrombosis and disseminated intravascular coagulation are common complications of cancer. Specific conditions associated with cancer such as stasis due to immobilization or blood flow obstruction, surgery, infections, endothelium damage due...

...Frederick R. Rickles; Mark N. Levine We have utilized epidemiological data to address three questions in patients with cancer and venous thromboembolism (VTE): (1) What is the risk for occult cancer in patients with idiopathic versus secondary VTE? (2) What is the risk for thrombosis in patients...

... cardiovascular damage are presented. On the other hand, a significantly higher occurrence of severe infections and chronic inflammatory processes was noted among the deficient patients. An increased incidence of cancer among the MPO-deficient individuals was not demonstrated. 24 11 2000 © 2000 S...